NanoSyrinx aims to transform drug administration by utilising a nature-inspired approach to cellular drug delivery, enabling safer, more effective treatments for patients. The company is repurposing natural "Nanosyringes" to unlock the interior of the cell by enabling targeted, intracellular delivery of protein therapeutics.

The company was founded by Dr Joe Healey in 2020 to commercialise the groundbreaking nano syringe technology discovered in the Waterfield Group based at the University of Warwick’s Medical School.